PATENT CLAIM ANALYSIS

Application Number: 16204748
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["546", "290000"]

Abstract:
The present invention includes novel substituted 1-hydroxy-pyridin-2(1H)-ones, which can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention inhibit HBV RNAse H activity.

Claim (Index 16):
The method of  claim 15 , wherein the at least one compound and the at least one additional agent are coformulated.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.17073
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16204584', '13796437', '16477533', '15512494', '16070014']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7535673807309585
- 35 USC 102 Novelty (BERT): 0.5190943143135176
- Combined Prediction Score: 0.7301200740892144
- Mean Citation Score: 280.055348
- Max Citation Score: 325.22662
- Similarity Product: 305.03716340143444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test